WHO MAY QUALIFY GLP-1 therapy may be appropriate for individuals with a body mass index (BMI) of 30 or higher, or for those with a BMI of 27 or higher who also have a weight-related condition such as obstructive sleep apnea, high blood pressure, or type 2 diabetes
Graf WD, Marin-Garcia J, Gao HG, Pizzo S, Naviaux RK, Markusic D et al
Its not comparable to prescription GLP-1 medications in terms of effectiveness or regulatory oversight
Selenium contributes to the maintenance of normal nails
Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytes
2.3 Western blot and antibodies The equal amounts (30 g) of protein lysed from aortic tissue and HUVECs, were separated by SDS-PAGE and then transferred onto polyvinylidene fluoride (PVDF) membranes (Merck Millipore, IPVH00010)